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CDThe conserved C-terminal FATC domain of the kinase ‘target of rapamycin’ is important for its reg-
ulation and was suggested to contain a peripheral membrane anchor. Here, we present the charac-
terization of the interactions of the yeast TOR1 FATC domain (2438–2470 = y1fatc) and 15 mutants
with membrane mimetic micelles, bicelles, and small unilamellar vesicles (SUVs) by NMR and CD
spectroscopy. Replacement of up to 6–7 residues did not result in a signiﬁcant abrogation of the
association with micelles or bicelles. However, replacement of only one residue could result in an
impairment of the interaction with SUVs that are usually used at low concentrations. Some mutants
not binding liposomes may be introduced in full-length TOR for future functional and localization
studies in vivo.
 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
The conserved multidomain serine/threonine kinase mamma-
lian/mechanistic target of rapamycin (mTOR) integrates different
cellular signals in response to nutrients and growth factors to cen-
trally regulate growth, metabolism and longevity [1,2]. Impair-
ment of TOR function is involved in the development of different
metabolic, cardiovascular, and neurodegenerative diseases [1–4].The TOR signaling network consists of two major branches, each
mediated by a speciﬁc complex with other proteins. TOR complex1
(TORC1) is very sensitive to the TOR-speciﬁc inhibitor complex
rapamycin-FKBP12 (FK506-binding protein of 12 kDa) and
regulates processes such as protein and lipid synthesis, ribosome
biogenesis, autophagy, glycolysis, and angiogenesis [5,6]. TOR
complex2 (TORC2) is rather insensitive to rapamycin and is in-
volved in the control of cytosceletal organization, gluconeogenesis,
and cell survival [5–7].
TOR proteins contain different functional regions (Fig. 1A). The
N-terminal HEAT repeat region (1200 residues) and the following
FRAP ATM TRRAP (FAT) domain (550 residues) are composed of
a-helical repeat motifs (HEAT, tetratricopeptide (TRP) repeats) that
typically form platforms mediating protein–protein interactions
[8–10]. The FKBP12–rapamycin-binding (FRB, 100 residues)
domain forms a four-a-helix bundle and contains the binding site
for the TOR-speciﬁc inhibitor complex composed of the cellular
protein FKBP12 and the macrolide rapamycin [11]. C-terminal of
the catalytic kinase domain (250–350 residues) is the highly
Fig. 1. Summary of the current structural data for the yeast TOR1 FATC domain (=y1fatc) and the current model for membrane association and NMR-monitored interaction
studies with neutral liposomes and diacyllipid micelles. (A) The top representation shows the structure of the free oxidized form [18]. As indicated, the FATC domain is at the
C-terminus of TOR and is in the full-length protein preceded by the kinase, the FRB, and the FAT domains. The N-terminal region is composed of HEAT repeats. The bottom
panel shows the structures of the micelle immersed oxidized and reduced y1fatc protein [23]. The model for membrane immersion has been derived based on the interaction
surface derived from a titration with DPC and the surface charge distribution and was modiﬁed from [23]. The membrane-solvent interface is indicated by a black dotted line.
The membrane lipids are schematically sketched by a blue circle for the headgroup and red, wavy lines for the acylchains. The backbone of the a-helix is depicted in red. The
side chains of aromatic residues (W, Y, F, H) are colored green, those of residues with methyl groups in the side chain (L, I, V, T, A) darker blue, and those of residues with polar
or charged side chains light blue. The conserved glycine is depicted in orange and the side chains of the disulﬁde bond forming cysteines in yellow. The structure of oxidized
micelle immersed y1fatc had to be determined at 318 K, because at lower temperatures the NMR signals for the micelle immersed region are partially not visible [23]. For
oxidized micelle immersed y1fatc, the side chains of W2466 and F2469 are shown for several structures of the calculated ensemble to indicate the greater structural
heterogeneity around these residues. The residues are labeled with the one-letter amino acid code and the sequence position in full-length yeast TOR1 (⁄: V2448, L2449,
I2450). (B) and (C) Superposition of the 1H-15N-HSQC spectra of oxidized wild type y1fatc in the absence and presence of DMPC SUVs and DihepPC micelles, respectively. The
color coding is indicated at the top of each plot. Both plots show in grey simple schematic representations of the respective membrane mimetic particles.
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SI Fig. S1A). This domain has been shown to play a very important
role for the regulation of TOR and the other phosphoinositide-3
kinase-related kinase (PIKK) family members [8,12–17].
Fig. 1A provides a summary of the current structural data for
the FATC domain of yeast TOR1 (residues 2438–2470 = y1fatc).
The structure of the free oxidized form consists of an a-helix that
is followed by a disulﬁde bonded loop (PDB-ID 1w1n). Reduction
of the disulﬁde bond formed between the highly conserved cyste-
ines C2460 and C2467 increases the ﬂexibility of the C-terminal
half, which may modulate the interactions with TOR regulators
[18]. Based on a ﬂuorescence assay the redox-potential of this
disulﬁde bond is 0.23 V and thus in a range allowing the redox
state to be modulated by typical cellular redox regulators.Additional in vivo mutagenesis studies in yeast showed that
replacement of one of the disulﬁde forming cysteines lowers the
cellular stability of TOR [18]. Consistent with this, a redox-sensitive
formation of TORC1 and its signaling function was suggested [19–
22]. Analysis of the FATC sequence with the program e-motif (G.
Tevzadze personal communication) suggested that the C-terminal
end that is rich in aromatic residues (Fig. 1A, SI Fig. S1A) might con-
tain a lipid binding motif. NMR-monitored binding studies with
different lipids and membrane mimetics showed that the TOR
FATC domain only interacts with lipids above the critical micelle
concentration (CMC), however does not show a very pronounced
preference for speciﬁc headgroups or membrane properties such
as surface charge and shape or the packing density of the lipid acyl
chains [23]. Both redox states of y1fatc can interact with
Table 1















F2469A No + n.d. n.d.
W2466A No + n.d. 
W2466A/W2470A No + n.d. 




Y2463D/I2464D/W2466A Yes + + 
Y2463D/I2464D/W2466E/W2470R Yes + + 
H2462R/Y2463D/I2464D/W2466A/
F2469D
Yes + + 
G2465S/W2466S Yes + + 
H2462R/Y2463D/I2464D/G2465S/
W2466S/F2469D
Yes + + 
L2459E/H2462R/Y2463D/I2464D/
G2465S/W2466A/F2469D
Yes + n.d. 
L2459S/H2462R/Y2463D/I2464D/
W2466E/F2469D
Yes + n.d. 
+ = Strong spectral changes indicating an interaction with the respective membrane
mimetic,  = no signiﬁcant spectral changes/interaction, n.d. = not determined.
* Regarding the interaction of the W2466A and W2466A/W2470 mutants with DPC
see [23].
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dimensional structures of the micelle immersed oxidized and
reduced forms (PDB-ID 2kio and 2kit) [23]. The association with
micelles maintains the overall fold of the oxidized state, however
the a-helix is stabilized and extends more to the C-terminus.
Although not restricted by a disulﬁde bond, the C-terminus of
the reduced micelle immersed state also folds back to the a-helix.
The orientation of side chains in the C-terminal micelle immersed
loop is however slightly different between the oxidized and the re-
duced form. Based on an estimate of the Kd from NMR diffusion
data, the oxidized form has a slightly higher afﬁnity for DPC mi-
celles than the reduced one [23]. In both micelle immersed states
the a-helix is slightly kinked and distorted around A2453, which
is presumably near the interface between the micelle and the sol-
vent. The initial model of the membrane immersion of the oxidized
and reduced TOR FATC domain shown in Fig. 1A was derived based
on the micelle-binding surface derived from the titration of oxi-
dized y1fatc with DPC and the surface charge distribution [23].
Based on this model the hydrophobic residues in the C-terminal
bulb-like region (I2456-W2470 in y1fatc) may penetrate the mi-
celle and interact with the hydrophobic acyl chains, whereas a
rim of charged residues (E2457, R2458, C-terminal carboxyl group
in y1fatc) may interact with charges in the lipid headgroups [23].
Based on recent NMR- and CD-monitored binding studies, the FATC
domains of the other human PIKK family members including atax-
ia-telangiectasia mutated (ATM), ataxia- and Rad3-related (ATR),
DNA-dependent protein kinase catalytic subunit (DNA-PKcs),
suppressor of morphogenesis in genitalia (SMG-1), and transfor-
mation/transcription domain-associated protein (TRRAP) can also
interact with membrane mimetics, which results generally in an
increase of the a-helical secondary structure content [24].
TOR has been localized at various cellular membranes such as
the plasma membrane and the outer membranes of the ER, Golgi,
mitochondria, lysosomes, and peroxisomes [22,25–31]. In addition
it was found in the nucleus and associated with ribosomes [32,33].
Direct membrane interactions of TOR may be mediated by the FRB
domain and as described above by the C-terminal FATC domain
[23,34,35]. Overall, the localization appears to depend on the exact
composition of the TOR complexes as well as on the cell type and
signaling state. Recently it has been highlighted that membrane
clustering inﬂuences the signal response and that spatial portion-
ing improves the reliability of biochemical signaling [36,37]. Thus
the speciﬁc signaling output of TOR may depend on its localization
[22], which likely is regulated by a network of protein–lipid/–
membrane and protein–protein interactions.
In order to better understand the importance of different mostly
conserved hydrophobic residues and a glycine in the y1fatc mem-
brane anchor for the interaction with different membranes, we
analyzed the interactions of wild type y1fatc and a large array of
mutants (Table 1) with different membrane mimetics (SI
Fig. S1B) by NMR and CD spectroscopy. Based on the presented
data the choice of the membrane mimetic and the concentration
at which it is used are important factors to detect small binding
differences between the wild type and mutant forms. Since some
of the mutated residues are also conserved in the FATC domains
of other PIKKs, the results are not only interesting to design full-
length mutants for TOR but also for the other PIKKs for in vivo
functional and localization studies.
2. Materials and methods
2.1. Mutagenesis and protein expression and puriﬁcation
The wild type FATC domain of yeast TOR1 (residues 2438–
2470 = y1fatc) was prepared as described earlier [18] and below.Replacement of one or more residues by alanine or other amino
acids was achieved by mutagenesis following the QuickChange site
directed mutagenesis protocol (Stratagene). Table 1 shows an over-
view of all prepared mutated FATC proteins. All proteins were
overexpressed in Escherichia coli BL21 (DE3) in LB or 15N-M9 min-
imal medium. The culture was grown until an OD600 of 0.7–0.9,
following induction with 1 mM IPTG for 3 h at 37 C. The fusion
protein consisting of the B1 domain of protein G (GB1), a thrombin
(LVPRGS) and a factor Xa (IEGR) site as well as y1fatc, as wild type
or mutated variant, (=y1fatc-gb1xa, 99 residues in total), was
mainly expressed soluble. If needed, the inclusion body fraction
was extracted as described [18]. The puriﬁcation of the fusion pro-
teins followed either the original protocol using ultrasonication for
cell lysis [18] or a heat shock protocol [38]. The lysis buffer was
always 50 mM Tris, 2 mM benzamidine, 2 mM EDTA, pH 7.5. GB1
fusion protein in the supernatant after cell lysis was extracted by
IgG afﬁnity chromatography as described in the manufacturer’s
manual (GE Healthcare). The puriﬁed protein was lyophilized and
resuspended in 50 mM Tris, 100 mM NaCl, pH 6.5 (NMR buffer).
If the GB1 fusion protein was directly used for NMR-monitored
binding studies as suggested recently [39], the resuspended pro-
tein was concentrated and washed several times with NMR buffer
using ultraﬁltration spin columns (Amicon Ultra, Merck Millipore,
MWCO 3000).
To obtain pure y1fatc, wild type or mutated, the IgG Sepharose
puriﬁed fusion protein resuspended in 50 mM Tris, 100 mM NaCl,
pH 8.0 containing additionally 2 mM CaCl2 was digested over-
night with factor Xa. The cleaved off fusion tag was subsequently
removed by RP-HPLC using a C4 column and an acetonitrile/triﬂu-
oroacetic acid buffer system and fractions containing pure y1fatc
or the mutated version were lyophilized and resuspended in
50 mM Tris, 100 mM NaCl, pH 6.5 as described [18]. The correct
molecular weight of the used proteins was conﬁrmed by mass
spectrometry.
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Dodecylphosphocholine (DPC) and 1,2-dimyristoyl-sn-glycero-
3-phosphocholine (DMPC) were purchased from Avanti Polar
Lipids. In addition, 1,2-Diheptanoyl-sn-glycero-3-phosphocholine
(DihepPC) and DMPC were obtained from Affymetrix. Deuterated
d38-DPC was bought from Cambridge Isotope Laboratories. For
the titrations with different lipids or lipid mixtures, the protein
concentration was in the range of 20–200 lM in 50 mM Tris,
100 mM NaCl, 0.02% NaN3 (95% H2O/5% D2O), pH 6.5. Lipid stock
solutions for the titrations or samples with a deﬁned lipid concen-
tration were prepared as follows. A deﬁned amount of lipid from a
concentrated stock in chloroform was placed in a glass vial and
dried under a stream of nitrogen gas. The dried lipid was then
dissolved in buffer or the protein sample and the pH adjusted to
6.5. For the samples with DMPC/DihepPC bicelles (q = 0.2,
[DMPC] = 0.032–0.04 M, [DihepPC] = 0.16–0.20 M corresponding
to cL = 12–15%) the appropriate amount of a DMPC stock solution
in chloroform was placed in a glass vial and dried under a stream
of nitrogen gas. Bicelles were formed by stepwise addition of the
appropriate amount of a DihepPC stock solution in buffer and vig-
orous vortexing after each step. Lastly, the protein solution was
added and everything mixed by vortexing.
For the preparation of liposomes, an appropriate amount of
DMPC in chloroform needed for a 50 mM solution was placed in
a glass vial and dried under a stream of nitrogen gas. The lipid
was resuspended in buffer and dissolved by seven cycles of freez-
ing in liquid nitrogen, incubation in a water bath at 40 C, and vig-
orous vortexing. The formation of small unilamellar vesicles (SUVs)
was induced by incubation in an ultrasonic bath for about half an
hour (T kept < 30–35 C). After centrifugation for 5 min at maxi-
mum speed in a table top centrifuge the clear supernatant of the
suspension was used for the NMR samples (using the 50 mM stock
solution the ﬁnal sample contained <30 mM DMPC). The ﬂuffy
white precipitate containing large uni- and multilamellar vesicles
was discarded.
2.3. Sample preparation for CD experiments
The protein concentration for CD experiments of wild type and
mutant y1fatc proteins was about 30 lM in 50 mM Tris, 100 mM
NaCl, pH 6.5. The samples in the presence of micelles, bicelles, or
liposomes were prepared as described for the NMR samples.
2.4. NMR spectroscopy
NMR spectra were acquired at 298 and 318 K on Bruker Avance
500 and 750 MHz spectrometers, the 500 MHz one equipped with
a cryogenic probe. The data were processed with NMRPipe [40] and
analyzed using NMRView [41].
2.5. CD spectrometry
CD spectra were recorded on a Jasco J-715 spectropolarimeter at
25 C in the range of 190–260 nm using a quartz cuvette with a
path length of 0.1 cm. All spectra were recorded with an acquisi-
tion time of 50 nm per minute and 5 scans. The response time
was 8 s.
3. Results
3.1. The TOR FATC domain interacted with DMPC liposomes and
DihepPC micelles
Recently we have shown that yeast TOR1 FATC domain
(residues 2438–2470 = y1fatc, Fig. 1A, SI Fig. 1A) can interact withneutral DPC micelles (Fig. 2A), negatively charged membrane mi-
metic particles prepared from dioctanoyl-phosphatidic acid (PA),
a 4:1 mixture of dioctanoyl- and dioleoyl-PA, or dihexanoyl-phos-
pho-inositol-3,4,5-trisphosphate and DPC, and with neutral
DihepPC/DMPC bicelles (Fig. 3A) and determined the structures
of oxidized and reduced y1fatc immersed in DPC micelles [23].
Since liposomes are considered a more realistic mimetic for nat-
ural membranes than micelles or bicelles, we ﬁrst analyzed if
y1fatc can also interact with neutral DMPC small unilamellar ves-
icles (SUVs, SI Fig. S1B). In the presence of liposomes at a DMPC
concentration below 30 mM (Fig. 1B) several peaks of y1fatc disap-
peared in the respective 1H-15N-HSQC spectra. This indicated that
y1fatc interacted with the large DMPC SUVs, resulting in a broad-
ening of most of its NMR signals beyond detection.
Although DPC has as DMPC a neutral phosphocholine head-
group, it resembles with its single fatty acid chain more a lysolipid
(SI Fig. S1B). In previous studies the interaction with micelles com-
posed of a lipid with two acyl chains has only been analyzed using
negatively charged dioctanoyl-PA. The resulting spectral changes
were overall similar as with DPC [23]. For completion and because
DihepPC is used as rim component in the below described interac-
tion studies with bicelles, we characterized also the interaction
with micelles composed of the neutral diacyllipid DihepPC (SI
Fig. 1B). The overall NMR spectral changes in the presence of
DihepPC micelles (Fig. 1C) were similar as with DPC micelles
(Fig. 2A) and DMPC/DihepPC bicelles (Fig. 3A). Based on the pre-
sented and earlier data [23], the wild type FATC domain of TOR
binds to membrane mimetics as diverse as micelles, bicelles, and
liposomes and to membrane mimetics composed of only neutral
components or containing additionally negatively charged lipids
such as phosphatidic acid (PA), or phosphatidylinositol lipids
(PIPs). In combination, these data conﬁrm that the wild type TOR
FATC domain does not show strong speciﬁc preferences for mem-
brane properties such as the presence of speciﬁcally shaped head-
groups or the surface charge and curvature or the packing
properties of the lipid acyl chain.
3.2. Mutation of up to 7 residues in the y1fatc membrane anchor did
not abrogate the interaction with DPC micelles
Tryptophans are known to play an important role for the mem-
brane interactions of proteins and short tryptophan-rich peptides
can interact with membrane mimetics [42,43]. Because of this,
the effect of replacing one or both tryptophans by alanine (y1fatc
W2466A and W2466/W2470A) on the interaction with DPC mi-
celles has been analyzed in initial mutagenesis studies. However,
neither mutant showed a strongly reduced afﬁnity for DPC micelles
[23]. This suggested that the other aromatic and aliphatic residues
in the y1fatc membrane anchor (Fig. 1A) contribute signiﬁcantly to
the binding afﬁnity. To better understand the role of the other
hydrophobic residues and of the conserved glycine for the interac-
tion with membrane mimetics and to ﬁnd a mutant that no longer
interacts with membrane mimetics for future in vivo functional
and localization studies, we analyzed the interactions of 13 addi-
tional y1fatc mutants (Table 1) with DPC micelles, DihepPC/DMPC
bicelles and DMPC liposomes of the SUV type by NMR and CD spec-
troscopy (Figs. 2–5, SI Figs. S2–S6).
DPC micelles are a well characterized membrane mimetic often
used for the structural characterization of membrane interacting
proteins [44–46]. Therefore, we ﬁrst probed the effect of mutations
on the binding afﬁnity by comparing for each mutant the 1H-15N-
HSQC spectra in the absence and presence of DPC micelles (Fig. 2,
SI Fig. S2/S3). First, additional y1fatc single mutant proteins were
prepared by replacing one hydrophobic residue at a time in the
membrane anchor by alanine (L2459A, H2462A, Y2463A, and
F2469A, Table 1). Fig. 2B shows representatively the superpositions
Fig. 2. NMR characterization of the interaction of the untagged and GB1-tagged yeast TOR1 FATC domain and selected mutants with membrane mimetic DPC micelles. (A–C)
Superposition of the 1H-15N-HSQC spectra of untagged y1fatc (A, adapted from [23]) and the Y2463A and Y2463E/W2466E mutants (B–C) in the free state at 298 K and in the
presence of DPC micelles at 298 K and 318 K. Increasing the temperature lowers the interaction with DPC micelles thereby enabling also the detection of signals
corresponding to the central region of the membrane anchor (e.g. green peak 108 ppm corresponding to G2465 in the bound state) [23]. The assignments for free y1fatc are
indicated with the one-letter amino acid code and the sequence position in full-length yeast TOR1 [18]. (D–F) Superposition of the 1H-15N-HSQC spectra of GB1-tagged wild
type y1fatc and the indicated mutants with 6 or 7 replacements in the absence and presence of DPC micelles. For all the spectrum of the GB1 tag alone that is followed by a
factor Xa site (=gb1xa) is shown on top in green to better differentiate the peaks of the FATC part and the tag. As shown earlier the GB1tag does not interact with membrane
mimetic micelles, bicelles, or SUVs [39]. Accordingly the respective peaks do not signiﬁcantly shift upon addition of the respective membrane mimetic. The color coding of all
NMR spectra and the used DPC concentrations are indicated at the top of each plot. (A) Shows in grey a simple schematic representation of the respective membrane mimetic
particle.
L.A.M. Sommer, S.A. Dames / FEBS Letters 588 (2014) 1755–1766 1759of the 1H-15N-HSQC spectra of the Y2463A mutant in the absence
(black) and presence (red) of a high concentration of DPC micelles
(100 mM DPC). The data for the L2459A, H2462A, and F2469A mu-
tants are given in Supplementary Fig. S2B–D. As the wild type
(Fig. 2A) and the W2466A mutant [23], all newly prepared single
mutants showed strong spectral changes and a spectrum different
from the free form with well-dispersed peaks. Thus all could still
interact with DPC micelles. Oxidized micelle immersed wild type
y1fatc at 298 K shows fewer peaks than expected based on the
number of residues in the sequence, because several of the peaksof the membrane anchor are not visible [23]. They become only
visible if the temperature is raised to 318 K, which reduces the
afﬁnity of the interaction with micelles (Fig. 2A green spectrum
and [23]). Based on a comparison of the number of peaks visible
for the respective micelle immersed y1fatc mutants at 298 and
318 K with the respective wild type data (Fig. 2A–B, SI Fig. S2), sin-
gle replacements by alanine had no strong effect on the afﬁnity. All
showed, like the wild type, an increase of the number of peaks at
318 K, which appeared only somewhat less for the mutant
Y2463A (Fig. 2B). However, some single mutants showed a greater
Fig. 3. NMR characterization of the interaction of the untagged and GB1-tagged yeast TOR1 FATC domain and selected mutants with membrane mimetic DMPC/DihepPC
bicelles (q 0.2, cL 12–15%). (A–B) Superposition of the 1H-15N-HSQC spectra of untagged oxidized y1fatc (A, adapted from [23]) and the Y2463D/I2464D/W2466Amutant (B) in
the absence and presence of bicelles. The insert in (A) shows the region for the tryptophan side chain amide groups that were spectrally folded due to a lower sweep width in
the 15N-dimension. The assignments for free y1fatc are indicated with the one-letter amino acid code and the sequence position in full-length yeast TOR1 [18]. (C–F)
Superposition of the 1H-15N-HSQC spectra of the GB1-tagged y1fatc mutants L2459A, Y2463A, Y2463E/W2466E, and H2462R/Y2463D/I2464D/G2465S/W2466S/F2469D in
the absence and presence of bicelles. For all the spectrum of the GB1 tag alone that is followed by a factor Xa site (=gb1xa) is shown on top in green to better differentiate the
peaks of the FATC part and the tag. As shown earlier the GB1tag does not interact with membrane mimetic micelles, bicelles, or SUVs [39]. (A) shows in grey a simple
schematic representation of the respective membrane mimetic particle.
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wild type protein. This was for example the case for the y1fatc mu-
tants Y2463A (Fig. 2B) and H2462A (SI Fig. S2C). Several peaks ap-
peared as some kind of doublet. For example, in the region
10 ppm, where in case of a single conformation (or very fast
dynamics), only one crosspeak should be visible for each side chain
amide group of the two tryptophans. Thus H2462 and Y2463 may
inﬂuence the backbone ﬂexibility at the C-terminal end of the a-
helix and in the disulﬁde bonded loop in the free and/or micelle
immersed state. Alternatively or in addition, they may inﬂuence
the rate of cis/trans isomerization of P2468 or alter the interactions
within the C-terminal loop and with the surrounding micellar
environment.Since replacement of one or even two aliphatic or aromatic res-
idues (for L2456A, H2462A, Y2463A, F2469A see Fig. 2B and SI
Fig. S2B–D and for W2466A, W2466A/W2470A see [23]) by the less
hydrophobic residue alanine did not signiﬁcantly reduce the inter-
action with DPC micelles, additional mutants were prepared in
which more hydrophobic residues were replaced by alanine or
even polar or charged residues (Table 1). The quadruple y1fatc mu-
tant Y2463A/I2464A/W2466A/W2470A showed, like the single or
double alanine mutants, strong spectral changes in the presence
of DPC micelles (SI Fig. S2E). This was similarly the case if two
hydrophobic residues had been replaced by negatively charged
amino acids as in the y1fatc mutants Y2463E/W2466E (Fig. 2C)
or Y2463D/I2463D/W2466A (SI Fig. S2F). However, for all these
Fig. 4. NMR characterization of the interaction of GB1-tagged or untagged wild type and mutated yeast TOR1 FATC proteins with DMPC SUVs and low concentrations of
DMPC. (A–D) Superposition of the 1H-15N-HSQC spectra of wild type GB1-tagged y1fatc (A, results for untagged see Fig. 1B) and the also GB1-tagged mutants L2459A and
Y2463A as well as the untagged mutant Y2463E/W2466E in the absence and presence of DMPC SUVs. The assignments for free GB1-tagged y1fatc are, as far as they could be
transferred from the untagged form, indicated with the one-letter amino acid code and the sequence position in full-length yeast TOR1 [18]. (E) and (F) Superposition of the
1H-15N-HSQC spectra of the GB1-tagged mutants Y2463E/W2466E and Y2463A in the absence and presence of increasing concentrations of DPC. The color coding of all NMR
spectra is indicated in each plot. For the spectral superpositions of GB1-tagged proteins the spectrum of the GB1 tag alone that is followed by a factor Xa site (=gb1xa) is
shown on top in green to better differentiate the peaks of the FATC part and the tag. As shown earlier the GB1tag does not interact with membrane mimetic micelles, bicelles,
or SUVs [39]. (A) shows in grey a simple schematic representation of the respective membrane mimetic particle.
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mersed form did not signiﬁcantly increase at higher temperature,
indicating a somewhat decreased afﬁnity for DPC micelles com-
pared to the wild type.
To ﬁnd a mutation that abrogates the interaction with mem-
brane mimetics, we designed additional mutants with more drastic
replacements of hydrophobic residues by polar or charged ones.
The preparation of the pure FATC domain is rather time-consuming
and expensive. Recently, we showed that the GB1 fusion tag does
not interact with membrane mimetic micelles, bicelles, or SUVs
[39]. Consequently, NMR-monitored interaction studies of addi-
tional y1fatc mutant proteins could be done using directly the
GB1-tagged protein. Because DPC has a small CMC (1.1 mM) and
the GB1-tagged wild type y1fatc showed still strong spectralchanges with 50 mM DPC (Fig. 2D), the interaction studies with
GB1-tagged mutant proteins were also done at this DPC concentra-
tion. Surprisingly, replacement of up to 6 hydrophobic residues
with mostly polar or charged residues (y1fatc-L2459S/H2462R/
Y2463D/I2464D/W2466E/F2469D) still did not abrogate the inter-
action with DPC micelles that were used at a lower concentration
as in the initial binding studies (Fig. 2E, SI Figs. S3A and B).
Thus, additional y1fatc mutants were prepared in which G2465
that was suggested to facilitate the formation of the disuﬂide bond
was replaced by serine (y1fatc-G2465S/W2466S, -H2462R/
Y2463D/I2464D/G2465S/W2466S/F2469D, and -L2459E/H2462R/
Y2463D/I2464D/G2465S/W2466A/F246D). The hypothesis was
that this mutant may not as easily form the C-terminal bulb-like
structure determined for the oxidized as well as reduced micelle
Fig. 5. CD spectra of the untagged yeast TOR1 FATC domain and mutants in the absence (red) and presence of membrane mimetics (blue). (A–C) CD spectra of wild type
y1fatc in the absence and presence of DPC micelles (always 50 mMDPC), DMPC/DihePC bicelles and DMPC SUVs. The CD spectra of bicelles are generally of lower quality since
the bicelles produce themselves a very strong CD signal (see SI Fig. S6A). (D–L) CD spectra of mutants that were prepared in the untagged form. The respective mutations are
indicated at the top of each plot. The determination of the concentration for the quadruple alanine mutant (L) based on UV measurements was not as accurate as for the other
mutants since this mutant had only one phenylalanine left and thus a very low extinction coefﬁcient. The color coding of the spectra is given in each plot. SI Fig. S6 shows
additionally the CD spectra of bicelles and SUVs in buffer and in the presence of untagged y1fatc-Y2463D/I2464D/W2466A and GB1-tagged y1fatc-L2459A.
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mutants were still able to interact with membrane mimetic DPC
micelles (Fig. 2F, SI Fig. S3C,D). Moreover, based on the spectral dif-
ferences after the addition of the reducing agent TCEP to two of
them (SI Fig. S3E–F), they were still able to form the disulﬁde bond.
This was presumably possible because G2465 was replaced by the
still relatively small serine and because one or more residues with
bulky side chain such as W2466 had additionally been replaced by
smaller residues. In summary, all tested new 13 as well as the
earlier generated W2466A and W2466A/W2470 y1fatc mutantscould still interact with DPC micelles at the typically used rather
high concentrations (P50 mM, Table 1 and [23]).
3.3. Mutation of up to 6 residues of y1fatc membrane anchor did not
abrogate the interaction with DihepPC/DMPC bicelles
Because DPC micelles are rather small spherical particles with a
high curvature and because DPC is also used as detergent, we fur-
ther analyzed the association of various y1fatc mutants with
DMPC/DihepPC bicelles that have a planar region consisting of a
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HSQC spectra of wild type and several mutant y1fatc proteins in
the free form and with DMPC/DihepPC bicelles are shown in
Fig. 3 (A–B untagged wild type and Y2463D/I2464D/W2466A,
C–F Gb1-tagged y1fatc-L2459A, -Y2463A, -Y2463E/W2466E,
-H2462R/Y2463D/I2464D/G2465S/W2466S/F2469D) and SI Fig. S4
(Gb1-tagged y1fatc-Y2463D/I2464D/W2466E/W2470R, -H2462R/
Y2463D/I2464D/W2466A/F2469D, -G2465S/W2466S). Indicated
by the strong spectral differences between the spectra in the
absence (in black) and presence of bicelles (in red), all tested y1fatc
mutants (Table 1) showed still a signiﬁcant afﬁnity for bicelles at
the used high lipid concentrations (200–240 mM), even y1fatc-
H2462R/Y2463D/I2464D/G2465S/W2466S/F2469D (Fig. 3F) in
which 6 residues of the membrane anchor had been replaced by
polar or charged residues.
3.4. Mutation of only a single residue of the y1fatc membrane anchor
could signiﬁcantly reduce the afﬁnity for DMPC liposomes
The observation that all tested y1fatc mutants could still inter-
act with DPC micelles or DihepPC/DMPC bicelles at the usually
used high concentrations, suggested that these two membrane
mimetics may not be ideally suited to detect signiﬁcant binding
differences that allow to ﬁnd a mutation that may abrogate the
interaction of full-length TOR with cellular membranes in in vivo
experiments. Therefore, we ﬁnally analyzed the interaction of sev-
eral y1fatc mutants with DMPC SUVs that may better mimic natu-
ral membranes (Fig. 4A, SI Fig. S1B) and that are usually prepared
from lower lipid concentrations (ﬁnal concentration in sample
<30 mM DMPC). As described above untagged oxidized wild type
y1fatc interacts with DMPC liposomes of the SUV type, resulting
in the disappearance of the majority of its resonances (Fig. 1B).
The same can be observed if DMPC SUVs are added to GB1-tagged
wild type y1fatc (Fig. 4A). If L2459 in the N-terminal part of the
membrane anchor (Fig. 1A) was replaced by the smaller but still
hydrophobic alanine, y1fatc could still interact with DMPC SUVs
(Fig. 4B). However, replacement of only one or two aromatic resi-
dues in the more central region of the membrane anchor
(Fig. 1A) by alanine or glutamate (Y2463A & Y2463E/W2466E
Fig. 4C–D, W2466A & W2466A/W2470A SI Fig. S5C–D) in GB1-
tagged or untagged y1fatc basically abrogated the interaction with
DMPC SUVs. Accordingly the 1H-15N-HSQC spectra in the presence
of liposomes, which are shown in red, almost completely superim-
pose with ones in the absence of liposomes in black, which are thus
mostly not visible anymore. Not astonishingly, mutation of three or
more residues resulted also not in signiﬁcant spectral changes (SI
Fig. S5B, F–K, Table 1).
Since SUVs at the usually used low concentrations allowed to
clearly detect binding differences between y1fatc wild type and
mutant proteins, we ﬁnally analyzed if a comparison of the titra-
tions with DPC at lower concentrations (0 to 630 mM) provides
complementary insights. Fig. 4E and F shows the titrations of the
GB1-tagged y1fatc Y2463A and Y2463E/W2466E with DPC. Both
mutants did not show signiﬁcant spectral changes with liposomes
(Fig. 4C and D). In the titration with DPC, the majority of peaks for
the single mutant Y2463A (Fig. 4E) disappear already at the ﬁrst
concentration step (2.5 mM) above the CMC of DPC (1.1 mM). Thus
this mutant behaved in the titration similar as the wild type and
the W2466A and W2466A/W2470A mutants [23]. In contrast, the
double mutant Y2463E/W2466E (Fig. 4F) showed still most peaks
at 2.5 mMDPC and the majority of signals started only to disappear
or shift at the next titration step (5 mMDPC). Therefore the relative
afﬁnity for DPC micelles is clearly lower for the Y2463E/W2466E
compared to the Y2463A mutant. Note that the peaks for the
micelle immersed state become usually only well visible at higher
DPC concentrations when the equilibrium is further shifted to thebound state (see for example the spectra of the Y2463A and
Y2463E/W2466E mutants in the presence of 100 mM DPC in
Fig. 2B and C).
In summary, the NMR-monitored interaction studies of y1fatc
with different membrane mimetics at different concentrations
showed that at least in case of the TOR FATC domain high concen-
trations of micelles and bicelles appear not suitable to ﬁnd rather
moderate mutations that abrogate membrane interactions. Only
the use of DMPC SUVs at low concentrations resulted in clearly
detectable binding differences between wild type and different
mutant y1fatc proteins. Complementary titrations with low con-
centrations of DPC allowed further to qualitatively compare the
relative afﬁnities for DPC micelles.
3.5. CD data indicated that the presence of membrane mimetic
micelles, bicelles, and liposomes increase the content of a-helical
secondary structure. The tested single to quadruple mutants showed
the same effect with micelles
Since only the structures of the oxidized and reduced wild type
DPC micelle immersed states have been determined previously
[23], we ﬁrst analyzed by CD, if the presence of bicelles and SUVs
results also in an increase of the a-helical secondary structure con-
tent. As can be seen from a comparison of Fig. 5A–C this is indeed
the case. The CD data in presence of bicelles is usually of signiﬁ-
cantly less quality since bicelles themselves produce already a
huge signal (SI Fig. S6A). The signal from SUVs at the usually used
low concentrations is generally rather small (SI Fig. S6B), however
can produce a positive signal of a few mdeg (SI of [34]). For both
bicelles and SUVs the produced signal can slightly vary from one
preparation to another, especially if the lipid concentration is not
exactly the same. For this reason the buffer reference measure-
ments should always be done using the same batch of bicelle or
SUV preparation as used for the protein sample (see also SI of
[34]). Since DPC micelles produce no signiﬁcant signal (SI of [34])
they are overall more convenient to be used for CD measurements.
Based on the CD measurements of wild type y1fatc (Fig. 4A) and
9 different mutants with one to four mutations, addition of DPC
micelles (50 mM, Fig. 4D–L) resulted for all in a signiﬁcant increase
in the a-helical secondary structure content. This is consistent
with the ability to interact with DPC micelles indicated by the
NMR data (Fig. 2, SI Figs. S2 and S3). However, the ratio of the
CD signal at the a-helix typical minima at 208 and 222 nm varied
slightly. Whereas the spectra of the free y1fatc mutants L2459A
and H2462A have overall a similar shape as the wild type, indicat-
ing a similar degree of a-helicity in the free state, the spectra of the
y1fatc mutants Y2463A, W2466A, F2469A, W2466A/W2470A,
Y2463E/W2466E, Y2463D/I2464D/W2470A, and the quadruple
alanine mutant Y2463A/I2464A/W2466A/W2470A appeared to
have to a varying degree a bigger contribution from an unfolded
protein signal, which was the most pronounced for the quadruple
mutant. The CD spectra of the quadruple alanine mutant and the
F2469A mutant indicate also a slightly higher contribution from
an unfolded protein signal in DPC micelle immersed state. For
the untagged triple y1fatc mutant Y2463D/I2464D/W2466A and
the GB1-tagged single mutant L2459A we also recorded CD spectra
in the absence and presence of bicelles and SUVs (SI Fig. S6C–F).
Consistent with the NMR data that indicated an interaction with
bicelles but no signiﬁcant one with SUVs for the Y2463D/I2464D/
W2466A mutant (Fig. 3B, SI Fig. S5B), bicelles resulted in an
increase of a-helical secondary structure, whereas the SUVs
induced no signiﬁcant CD spectral changes. Also in agreement with
the NMR data (Figs. 3C and 4B), the moderate L2459 mutant
showed CD spectral changes with both membrane mimetics.
Thus the CD-monitored interaction data overall conﬁrmed the
NMR-monitored one.
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The membrane anchor in the FATC domain may represent one
component of a network of protein–lipid/–membrane and pro-
tein–protein interactions mediating and regulating TOR localiza-
tion, thus allowing a speciﬁc local signaling response. To better
understand the role of different residues of the FATC membrane
anchor for peripheral membrane association and to establish a
methodological framework to do this, we analyzed the interactions
of a whole ensemble of mutants with different membrane mimet-
ics by NMR and CD spectroscopy (Table 1, Figs. 2–5, SI Figs. S2–S6).
All mutants, even ones in which up to 6 or 7 residues of the hydro-
phobic C-terminal region had been mutagenized to mostly charged
residues, could still interact with DPC micelles and DihepPC/DMPC
bicelles (Figs. 2 and 3, SI Figs. S2–S4) at the usually used rather
high concentrations. An abrogation of y1fatc-membrane mimetic
interactions could only be detected if SUVs composed of DMPC
were used at low concentrations (Fig. 4A–D, SI Fig. S5). In this
experimental set-up, even mutation of only one hydrophobic resi-
due in the center of the C-terminal loop had a clearly detectable ef-
fect. The different association behavior of the y1fatc mutants with
micelles and bicelles compared to liposomes can be explained two-
fold. First, using micelles or bicelles the total concentration of the
used detergents or lipids is rather high and consequently also the
available membrane mimetic surface area. The used DPC concen-
trations were in the range of 50–200 mM and the total lipid con-
centrations in the bicelle sample was 200–240 mM. In contrast,
the total lipid concentration in the SUV preparation in the present
samples was signiﬁcantly below 30 mM since pure DMPC cannot
easily be resuspended at high concentrations and in addition some
of the lipid is lost when separating the small from larger uni- and
multilamellar vesicles by centrifugation. The latter results in a dis-
advantage of this SUV preparation method, namely that the ﬁnal
lipid concentration after centrifugation may vary from one prepa-
ration to another depending on different factors (storage time of
lipids before use, exact ultrasonication time and temperature,
etc.). This hampers a quantitative comparison of the respective
binding data. In 1D 1H NMR spectra, one does due to the large size
of SUVs only see small lipid signals and not as for DPC micelles or
DMPC/DihepPC bicelles really large ones, which allow to easily
compare the lipid content in the samples containing the latter
two membrane mimetics. Besides established methods such as dy-
namic light scattering, the CD signal may be used to compare dif-
ferent liposome preparations using the described as well as other
methods. The example CD spectrum in SI Fig. S6 shows only a weak
positive signal, however depending on the used concentration and
the preparation, SUVs can show a CD signal of several mdeg around
215 nm [34]. For future similar binding studies, more uniform SUV
preparations may be obtained by using an extruder with a deﬁned
pore size. A second reason for the different binding behavior of
y1fatc to micelles and bicelles versus SUVs may further be a some-
what higher afﬁnity of the TOR FATC membrane anchor for curved
and/or less densely packed membrane surfaces. This would be in
agreement with the observation that some of the tested mutants
can interact with rather low concentrations of DPC (around
1.1–5 mM, Fig. 4E and F and [23]). DPC micelles are rather small,
spherical particles (Fig. 2A, SI Fig. S1B) that contain 50–60 DPC
molecules, resulting in a molecular weight of 19 kDa [47].
Bicelles have a rather planar bilayer region that is formed by a long
chain phospholipid such as DMPC (Fig. 3A, SI Fig. S1B). However
the rim that is formed by a short chain lipid such as DihepPC shows
as micelles also a high curvature. The molecular weight of bicelles
is usually >250 kDa [48]. Even liposomes of the SUV type are much
larger than bicelles. Although they are as micelles approximately
spherical, they are less curved since the radius is much larger
(Fig. 4A, SI Fig. S1B). Overall, our binding studies with differentmutants suggest that for proteins with a rather high and broad
afﬁnity for different membrane mimetics, SUVs that are usually
used at lower concentrations appear generally better suited to de-
tect binding differences and thus to ﬁnd mutants that may also
abrogate membrane association in localization studies in cells. In
addition, complementary titrations with DPC at low concentrations
(0 to 30 mM) such as shown in Fig. 4E and F can be used to com-
pare the relative membrane mimetic binding afﬁnity of different
mutants. These studies show however also that every membrane
mimetic has its advantages and disadvantages and that it is overall
not a trivial task to choose the right concentration to mimic the
available membrane surface area in the cell, also because the latter
is experimentally not easily determined. Nevertheless, testing in
cellular localization and functional assays different TOR full-length
proteins containing FATC mutations, which abrogated the interac-
tion with SUVs in the presented data (Table 1, see also detailed dis-
cussion below), should provide useful insights about the role of the
FATC domain for TOR localization and function.
The observation that mutants of the TOR FATC domain with as
many as 6–7 replacements could still interact with DPC micelles
and DihepPC/DMPC bicelles suggest two things (Table 1). First,
hydrophobic interactions of the remaining hydrophobic residues
in the membrane anchor (e.g. W2470, P2468, L2459, and I2456
in the mutant y1fatc H2462R/Y2463D/I2464D/G2465S/W2466S/
F2469D) as well as additional polar interactions of the introduced
charged residues with the positive and negative charges of the cho-
line headgroup are still sufﬁcient to maintain a well detectable
afﬁnity for micelles and bicelles. Moreover, the interactions with
residues N-terminal of the hydrophobic bulb like regions may be
more important for the interactions with membrane mimetics than
initially expected. Second, the observation that a rather highly mu-
tated FATC domain showed still signiﬁcant spectral changes with
micelles or bicelles may suggest that many peptides or small pro-
teins may unspeciﬁcally interact with these membrane mimetics.
However, we have ourselves analyzed several small proteins or
peptides that do not interact with DPC micelles and/or DihepPC/
DMPC bicelles. The NMR data from the present (Figs. 2–4, SI
Figs. S3–S5) as well as from previous studies indicated that the
B1 domain of streptococcal protein G (GB1), alone or fused to other
proteins, does not interact with DPC micelles, DihepPC/DMPC bi-
celles, or SUVs [24,39]. Recently, we further characterized the
interaction of the N-terminal domain of Formin C, of a 26-mer pep-
tide corresponding to a large unstructured loop of this domain, and
of a mutant form lacking this loop with different membrane
mimetics. To mimic the restriction of mobility in the full-length
protein, the 26-mer peptide could further be circularized by oxida-
tion of terminal cysteines. Whereas the full N-terminal domain and
the mutant form lacking the loop showed strong spectral changes
in the presence of pure DPC micelles and even more if containing
negatively charged lipids, neither the reduced nor the oxidized
26-mer peptide showed any spectral changes in CD or NMR spectra
upon addition of 50 mM DPC [49]. In contrast to the y1fatc protein
analyzed in this study, the Formin C N-terminal domain showed
only very minor spectral changes with bicelles, presumably be-
cause its interaction with membrane mimetics may be more sensi-
tive to the packing and accessibility of the hydrophobic acyl chains
and not only to the curvature [49]. Another example for a protein
region that shows no interactions with DPC micelles is the N-ter-
minal natively unstructured region of the mycobacterial kinase G
(PknG, residues 1–76, Uniprot ID P65728) (unpublished data).
Finally, two more examples for proteins that show as all tested
TOR FATC mutants strong spectral changes with micelles and bi-
celles but only weak ones with SUVs are the FRB domain of TOR
[34] and the FATC domain of the PIKK DNA-PKcs [24]. Generally,
the different afﬁnities for different membrane mimetics can often
be rationalized based on the current knowledge of the protein
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very speciﬁc membrane regions, show overall only a signiﬁcant
afﬁnity for membrane mimetics that mimic features of the natural
target membranes such as the presence of speciﬁc lipids like PIPs
or the surface curvature [44,50–52].
The interaction studies with SUVs indicated that replacement of
one or two residues may be sufﬁcient to also abrogate the binding
of the TOR FATC domain to cellular membranes. Based on our data
the moderate single mutations Y2463A (Fig. 4C) and W2466A (SI
Fig. S5C) and, or the more harsh double mutants Y2463E/
W2466E (Fig. 4D) W2466A/W270A (SI Fig. S5D) could be useful
to be incorporated in full-length yeast TOR1 or TOR from a higher
eukaryote for in vivo studies to evaluate the role of the FATC do-
main for the localization and function of TOR. All three residues
are in the bulb-like C-terminal region (Fig. 1A). Based on the struc-
tures of the free oxidized and the micelle immersed oxidized and
reduced states Y2463 and W2466 appear not to be too critical for
loop formation but rather for its interactions, whereas W2470
mediates some intramolecular contacts [18,23]. The comparison
of the 1H-15N-HSQC spectra of all these mutants with the one of
the wild type indicate that they all can form the disulﬁde bond be-
tween C2460 and C2467 (Figs. 2–4 and [23]). Indicated by the dee-
per minimum around 222 nm in the CD data (Fig. 5), the alanine
mutants W2466A, W2466A/W2470A, and Y2463A maintain in
the free state a slightly higher degree of a-helicity as the double
glutamate mutant Y2463E/W2466E. Based on the alignment of
the sequences of the FATC domain of different human PIKKs (SI
Fig. S1A), mutation of these positions is also interesting with re-
spect to the other PIKKs. The position corresponding to W2466 in
y1fatc is in all PIKKs occupied by a tryptophan. The position corre-
sponding to Y2463 is in all except TRRAP occupied by an aromatic
residue. TRRAP differs overall a bit from the consensus features of
the other PIKKs, also since it is the only family member not show-
ing catalytic kinase activity [13]. The position corresponding to
y1fatc W2470 is in all occupied by a hydrophobic residue. If the ef-
fect of mutating only one or two residues may not be sufﬁcient to
abrogate the interaction with cellular membranes, because the
interaction of the large membrane mimetic interface of y1fatc is
stronger than with low concentrations of SUVs, the tested triple
or quadruple mutants (Table 1) may be introduced in full-length
TOR for in vivo studies.
Based on a docking model of a newly determined crystal
structure of truncated human TOR in complex with LST8 with a
substrate peptide, the FATC domain interacts with the kinase
domain and with one residue also with LST8, providing a hydro-
phobic surface region that may not only mediate substrate [53],
but also membrane interactions. Y2452 andW2545, corresponding
to Y2463 and W2466 in y1fatc, are part of this hydrophobic patch.
Thus mutating either one or both of these residues may inﬂuence
substrate binding as well as interactions with membranes and reg-
ulator proteins, some of which are known to reside at membranes
such as farnesylated Rheb [54] or the Ragulator-Rag complex [28].
Therefore, future in vivo localization studies have to include refer-
ence experiments such as in vitro kinase or interaction assays to
separate the different effects. In addition it has to be considered
that the interaction of the FATC domain with the kinase domain
or other components of the two TOR complexes as well as with
membrane lipids and regulator proteins may be modiﬁed by cellu-
lar redox agents [18,23]. Additional information about the accessi-
bility of the FATC domain can be obtained from EM structures of
yeast TOR1 alone and in complex with the Raptor yeast-homolog
KOG1. In the uncomplexed form, the FATC domain appeared like
a protruding ﬁnger and thus accessible for potential membrane
interactions. Due to the low resolution (25 Å) the accessibility
in the complexed form could however not be clearly evaluated
[55].In conclusion, we analyzed in detail the effect of mutating one
or more residue of the hydrophobic membrane anchor of the FATC
domain of TOR on the association behavior with membrane mi-
metic micelles, bicelles, and liposomes. For a protein like y1fatc,
with a broad membrane mimetic binding afﬁnity, only NMR-based
interaction studies employing SUVs at low concentrations were
useful to clearly detect mutations that may also abrogate mem-
brane interactions in vivo. Complementary titration studies with
DPC at low concentrations allowed additionally to compare differ-
ences in the binding afﬁnity for mutants showing a signiﬁcantly re-
duced interaction with liposomes. The complementary CD data
conﬁrmed the NMR interaction data and allowed to estimate the
differences in the secondary structure content between the free
and micelle immersed wild type and mutant proteins. Some of
the mutants not binding to liposomes may be incorporated in
full-length TOR for in vivo functional and localization studies,
which will help to better understand the role of the redox-sensitive
FATC domain for the regulation of TOR localization at different cel-
lular membranes and its local signaling activity. Recent studies
suggest that the ability to interact with membrane mimetics is also
shared by the FATC domains of the other PIKKs [24]. The presented
binding data of different TOR FATC mutants it also helpful to better
rationalize, why the FATC domains of all tested PIKKs can interact
with membrane mimetics, although with apparently somehow dif-
ferent preferences for different membrane properties such as sur-
face charge, shape, and curvature and the acyl chain packing
density. Finally, the small FATC domain might be linked to other
proteins or substances to tether them to membrane mimetics, for
example lipid bilayers attached to solid phases.Funding sources
This work was supported by Grants from the German Research
Foundation to S.A.D. (DA 1195/3-1 and collaborative research cen-
ter 1035, subproject B04). S.A.D and L.A.M.S. acknowledge further
ﬁnancial support from the TUM diversity and talent management
ofﬁce and S.A.D. additionally from the project ‘metabolic dysfunc-
tion’ of the Helmholtz Zentrum München.Acknowledgements
The following (former) TUM biochemistry bachelor students we
thank for their contributions to some of the protein puriﬁcations
and/or some of the NMR- and CD-measurements: Melanie Meier,
Ann-Kathrin Flörsheimer, Tanja Kraus, Tamara Heermann. The
groups of Prof. Dr. S. Grzesiek and Prof. Dr. M. Hall from the
Biozentrum in Basel we acknowledge for support during the initial
phase of the project around TOR. Prof. Dr. M. Sattler from the TU
München/Helmholtz Zentrum München I thank very much for
hosting my group and for his continuous support.Appendix A. Supplementary data
Supplementary data associated with this article can be found, in
the online version, at http://dx.doi.org/10.1016/j.febslet.2014.
03.031.
References
[1] Laplante, M. and Sabatini, D.M. (2012) MTOR signaling in growth control and
disease. Cell 149, 274–293.
[2] Dazert, E. and Hall, M.N. (2011) MTOR signaling in disease. Curr. Opin. Cell
Biol. 23, 744–755.
[3] Yang, Z. and Ming, X.F. (2012) MTOR signalling: the molecular interface
connecting metabolic stress, aging and cardiovascular diseases. Obes. Rev. 13
(Suppl 2), 58–68.
1766 L.A.M. Sommer, S.A. Dames / FEBS Letters 588 (2014) 1755–1766[4] Blagosklonny, M.V. and Hall, M.N. (2009) Growth and aging: a common
molecular mechanism. Aging (Albany, NY) 1, 357–362.
[5] Appenzeller-Herzog, C. and Hall, M.N. (2012) Bidirectional crosstalk between
endoplasmic reticulum stress and mTOR signaling. Trends Cell Biol. 22, 274–
282.
[6] Loewith, R., Jacinto, E., Wullschleger, S., Lorberg, A., Crespo, J.L., Bonenfant, D.,
Oppliger, W., Jenoe, P. and Hall, M.N. (2002) Two TOR complexes, only one of
which is rapamycin sensitive, have distinct roles in cell growth control. Mol.
Cell 10, 457–468.
[7] Sarbassov, D.D., Ali, S.M., Sengupta, S., Sheen, J.H., Hsu, P.P., Bagley, A.F.,
Markhard, A.L. and Sabatini, D.M. (2006) Prolonged rapamycin treatment
inhibits mTORC2 assembly and Akt/PKB. Mol. Cell 22, 159–168.
[8] Bosotti, R., Isacchi, A. and Sonnhammer, E.L. (2000) FAT: a novel domain in
PIK-related kinases. Trends Biochem. Sci. 25, 225–227.
[9] Knutson, B.A. (2010) Insights into the domain and repeat architecture of target
of rapamycin. J. Struct. Biol. 170, 354–363.
[10] Groves, M.R. and Barford, D. (1999) Topological characteristics of helical
repeat proteins. Curr. Opin. Struct. Biol. 9, 383–389.
[11] Choi, J., Chen, J., Schreiber, S.L. and Clardy, J. (1996) Structure of the FKBP12-
rapamycin complex interacting with the binding domain of human FRAP.
Science 273, 239–242.
[12] Takahashi, T., Hara, K., Inoue, H., Kawa, Y., Tokunaga, C., Hidayat, S., Yoshino,
K., Kuroda, Y. and Yonezawa, K. (2000) Carboxyl-terminal region conserved
among phosphoinositide-kinase-related kinases is indispensable for mTOR
function in vivo and in vitro. Genes Cells 5, 765–775.
[13] Lempiainen, H. and Halazonetis, T.D. (2009) Emerging common themes in
regulation of PIKKs and PI3Ks. EMBO J. 28, 3067–3073.
[14] Morita, T., Yamashita, A., Kashima, I., Ogata, K., Ishiura, S. and Ohno, S. (2007)
Distant N- and C-terminal domains are required for intrinsic kinase activity of
SMG-1, a critical component of nonsense-mediated mRNA decay. J. Biol.
Chem. 282, 7799–7808.
[15] Hoke, S.M., Irina Mutiu, A., Genereaux, J., Kvas, S., Buck, M., Yu, M., Gloor, G.B.
and Brandl, C.J. (2010) Mutational analysis of the C-terminal FATC domain of
Saccharomyces cerevisiae Tra1. Curr. Genet. 56, 447–465.
[16] Jiang, X., Sun, Y., Chen, S., Roy, K. and Price, B.D. (2006) The FATC domains of
PIKK proteins are functionally equivalent and participate in the Tip60-
dependent activation of DNA-PKcs and ATM. J. Biol. Chem. 281, 15741–15746.
[17] Mordes, D.A., Glick, G.G., Zhao, R. and Cortez, D. (2008) TopBP1 activates ATR
through ATRIP and a PIKK regulatory domain. Genes Dev. 22, 1478–1489.
[18] Dames, S.A., Mulet, J.M., Rathgeb-Szabo, K., Hall, M.N. and Grzesiek, S. (2005)
The solution structure of the FATC domain of the protein kinase target of
rapamycin suggests a role for redox-dependent structural and cellular
stability. J. Biol. Chem. 280, 20558–20564.
[19] Sarbassov, D.D. and Sabatini, D.M. (2005) Redox regulation of the nutrient-
sensitive raptor-mTOR pathway and complex. J. Biol. Chem. 280, 39505–
39509.
[20] Yoshida, S., Hong, S., Suzuki, T., Nada, S., Mannan, A.M., Wang, J., Okada, M.,
Guan, K.L. and Inoki, K. (2011) Redox regulates mammalian target of
rapamycin complex 1 (mTORC1) activity by modulating the TSC1/TSC2-Rheb
GTPase pathway. J. Biol. Chem. 286, 32651–32660.
[21] Neklesa, T.K. and Davis, R.W. (2008) Superoxide anions regulate TORC1 and its
ability to bind Fpr1:rapamycin complex. Proc. Natl. Acad. Sci. USA 105, 15166–
15171.
[22] Zhang, J., Kim, J., Alexander, A., Cai, S., Tripathi, D.N., Dere, R., Tee, A.R., Tait-
Mulder, J., Di Nardo, A., Han, J.M., Kwiatkowski, E., Dunlop, E.A., Dodd, K.M.,
Folkerth, R.D., Faust, P.L., Kastan, M.B., Sahin, M. and Walker, C.L. (2013) A
tuberous sclerosis complex signalling node at the peroxisome regulates
mTORC1 and autophagy in response to ROS. Nat. Cell Biol. 15, 1186–1196.
[23] Dames, S.A. (2010) Structural basis for the association of the redox-sensitive
target of rapamycin FATC domain with membrane-mimetic micelles. J. Biol.
Chem. 285, 7766–7775.
[24] Sommer, L.A., Schaad, M. and Dames, S.A. (2013) NMR- and circular
dichroism-monitored lipid binding studies suggest a general role for the
FATC domain as membrane anchor of phosphatidylinositol 3-kinase-related
kinases (PIKK). J. Biol. Chem. 288, 20046–20063.
[25] Berchtold, D. andWalther, T.C. (2009) TORC2 plasma membrane localization is
essential for cell viability and restricted to a distinct domain. Mol. Biol. Cell 20,
1565–1575.
[26] Drenan, R.M., Liu, X., Bertram, P.G. and Zheng, X.F. (2004) FKBP12-rapamycin-
associated protein or mammalian target of rapamycin (FRAP/mTOR)
localization in the endoplasmic reticulum and the Golgi apparatus. J. Biol.
Chem. 279, 772–778.
[27] Kunz, J., Schneider, U., Howald, I., Schmidt, A. and Hall, M.N. (2000) HEAT
repeats mediate plasma membrane localization of Tor2p in yeast. J. Biol.
Chem. 275, 37011–37020.
[28] Sancak, Y., Bar-Peled, L., Zoncu, R., Markhard, A.L., Nada, S. and Sabatini, D.M.
(2010) Ragulator-Rag complex targets mTORC1 to the lysosomal surface and is
necessary for its activation by amino acids. Cell 141, 290–303.
[29] Wedaman, K.P., Reinke, A., Anderson, S., Yates 3rd, J., McCaffery, J.M. and
Powers, T. (2003) Tor kinases are in distinct membrane-associated protein
complexes in Saccharomyces cerevisiae. Mol. Biol. Cell 14, 1204–1220.[30] Partovian, C., Ju, R., Zhuang, Z.W., Martin, K.A. and Simons, M. (2008)
Syndecan-4 regulates subcellular localization of mTOR Complex2 and Akt
activation in a PKCalpha-dependent manner in endothelial cells. Mol. Cell 32,
140–149.
[31] Liu, X. and Zheng, X.F. (2007) Endoplasmic reticulum and Golgi localization
sequences for mammalian target of rapamycin. Mol. Biol. Cell 18, 1073–1082.
[32] Zhang, X., Shu, L., Hosoi, H., Murti, K.G. and Houghton, P.J. (2002) Predominant
nuclear localization of mammalian target of rapamycin in normal and
malignant cells in culture. J. Biol. Chem. 277, 28127–28134.
[33] Zinzalla, V., Stracka, D., Oppliger, W. and Hall, M.N. (2011) Activation of
mTORC2 by association with the ribosome. Cell 144, 757–768.
[34] Rodriguez Camargo, D.C., Link, N.M. and Dames, S.A. (2012) The FKBP-
rapamycin binding domain of human TOR undergoes strong conformational
changes in the presence of membrane mimetics with and without the
regulator phosphatidic acid. Biochemistry 51, 4909–4921.
[35] Fang, Y., Vilella-Bach, M., Bachmann, R., Flanigan, A. and Chen, J. (2001)
Phosphatidic acid-mediated mitogenic activation of mTOR signaling. Science
294, 1942–1945.
[36] Mugler, A., Bailey, A.G., Takahashi, K. and Ten Wolde, P.R. (2012) Membrane
clustering and the role of rebinding in biochemical signaling. Biophys. J. 102,
1069–1078.
[37] Mugler, A., Tostevin, F. and Ten Wolde, P.R. (2013) Spatial partitioning
improves the reliability of biochemical signaling. Proc. Natl. Acad. Sci. USA.
[38] Koenig, B.W., Rogowski, M. and Louis, J.M. (2003) A rapid method to attain
isotope labeled small soluble peptides for NMR studies. J. Biomol. NMR 26,
193–202.
[39] Sommer, L.A.M., Meier, M.A. and Dames, S.A. (2012) A fast and simple method
for probing the interaction of peptides and proteins with lipids and
membrane-mimetics using GB1 fusion proteins and NMR spectroscopy.
Protein Sci. 21, 1566–1570.
[40] Delaglio, F., Grzesiek, S., Vuister, G.W., Zhu, G., Pfeifer, J. and Bax, A. (1995)
NMRPipe: a multidimensional spectral processing system based on UNIX
pipes. J. Biomol. NMR 6, 277–293.
[41] Johnson, B.A. (2004) Using NMRView to visualize and analyze the NMR spectra
of macromolecules. Methods Mol. Biol. 278, 313–352.
[42] Liu, W. and Caffrey, M. (2006) Interactions of tryptophan, tryptophan peptides,
and tryptophan alkyl esters at curved membrane interfaces. Biochemistry 45,
11713–11726.
[43] Sun, H., Greathouse, D.V., Andersen, O.S. and Koeppe 2nd, R.E. (2008) The
preference of tryptophan for membrane interfaces: insights from N-
methylation of tryptophans in gramicidin channels. J. Biol. Chem. 283,
22233–22243.
[44] Kutateladze, T.G., Capelluto, D.G., Ferguson, C.G., Cheever, M.L., Kutateladze,
A.G., Prestwich, G.D. and Overduin, M. (2004) Multivalent mechanism of
membrane insertion by the FYVE domain. J. Biol. Chem. 279, 3050–3057.
[45] Ahn, H.C., Juranic, N., Macura, S. and Markley, J.L. (2006) Three-dimensional
structure of the water-insoluble protein crambin in dodecylphosphocholine
micelles and its minimal solvent-exposed surface. J. Am. Chem. Soc. 128,
4398–4404.
[46] Nanga, R.P., Brender, J.R., Xu, J., Hartman, K., Subramanian, V. and
Ramamoorthy, A. (2009) Three-dimensional structure and orientation of rat
islet amyloid polypeptide protein in a membrane environment by solution
NMR spectroscopy. J. Am. Chem. Soc. 131, 8252–8261.
[47] Tieleman, D.P., van der Spoel, D. and Berendsen, H.J.C. (2000) Molecular
dynamics simulations of dodecylphosphocholine micelles at three different
aggregate sizes: micellar structure and chain relaxation. J. Phys. Chem. B 104,
6380–6388.
[48] Whiles, J.A., Deems, R., Vold, R.R. and Dennis, E.A. (2002) Bicelles in structure-
function studies of membrane-associated proteins. Bioorg. Chem. 30, 431–
442.
[49] Dames, S.A., Junemann, A., Sass, H.J., Schonichen, A., Stopschinski, B.E.,
Grzesiek, S., Faix, J. and Geyer, M. (2011) Structure, dynamics, lipid binding,
and physiological relevance of the putative GTPase-binding domain of
Dictyostelium formin C. J. Biol. Chem. 286, 36907–36920.
[50] Serth, J., Lautwein, A., Frech, M., Wittinghofer, A. and Pingoud, A. (1991) The
inhibition of the GTPase activating protein-Ha-ras interaction by acidic lipids
is due to physical association of the C-terminal domain of the GTPase
activating protein with micellar structures. EMBO J. 10, 1325–1330.
[51] Ramalingam, N., Zhao, H., Breitsprecher, D., Lappalainen, P., Faix, J. and
Schleicher, M. (2010) Phospholipids regulate localization and activity of
mDia1 formin. Eur. J. Cell Biol. 89, 723–732.
[52] Zimmerberg, J. and Kozlov, M.M. (2006) How proteins produce cellular
membrane curvature. Nat. Rev. Mol. Cell Biol. 7, 9–19.
[53] Yang, H., Rudge, D.G., Koos, J.D., Vaidialingam, B., Yang, H.J. and Pavletich, N.P.
(2013) MTOR kinase structure, mechanism and regulation. Nature 497, 217–
223.
[54] Buerger, C., DeVries, B. and Stambolic, V. (2006) Localization of Rheb to the
endomembrane is critical for its signaling function. Biochem. Biophys. Res.
Commun. 344, 869–880.
[55] Adami, A., Garcia-Alvarez, B., Arias-Palomo, E., Barford, D. and Llorca, O. (2007)
Structure of TOR and its complex with KOG1. Mol. Cell 27, 509–516.
